TY - JOUR
T1 - HLA-Bâ27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope
AU - Nitschke, K.
AU - Barriga, A.
AU - Schmidt, J.F.
AU - Timm, J.
AU - Viazov, S.O.
AU - Kuntzen, T.
AU - Kim, A.
AU - Lauer, G.M.
AU - Allen, T.M.
AU - Gaudieri, Silvana
AU - Rauch, A.
AU - Lange, C.M.
AU - Sarrazin, C.M.
AU - Eiermann, T.H.
AU - Sidney, J.
AU - Sette, A.D.
AU - Thimme, R.
AU - López, D.H.
AU - Neumann-Haefelin, C.
PY - 2014
Y1 - 2014
N2 - Background & Aims HLA-Bâ27 is associated with spontaneous HCV genotype 1 clearance. HLA-Bâ27-restricted CD8+ T cells target three NS5B epitopes. Two of these epitopes are dominantly targeted in the majority of HLA-Bâ27+ patients. In chronic infection, viral escape occurs consistently in these two epitopes. The third epitope (NS5B2820) was dominantly targeted in an acutely infected patient. This was in contrast, however, to the lack of recognition and viral escape in the large majority of HLA-Bâ27+ patients. Here, we set out to determine the host factors contributing to selective targeting of this epitope. Methods Four-digit HLA class I typing and viral sequence analyses were performed in 78 HLA-Bâ27+ patients with chronic HCV genotype 1 infection. CD8+ T cell analyses were performed in a subset of patients. In addition, HLA/peptide affinity was compared for HLA-B â27:02 and 05. Results The NS5B2820 epitope is only restricted by the HLA-Bâ27 subtype HLA-Bâ27:02 (that is frequent in Mediterranean populations), but not by the prototype HLA-Bâ27 subtype Bâ27:05. Indeed, the epitope is very dominant in HLA-Bâ27:02+ patients and is associated with viral escape mutations at the anchor position for HLA-binding in 12 out of 13 HLA-Bâ27:02+ chronically infected patients. Conclusions The NS5B2820 epitope is immunodominant in the context of HLA-B â27:02, but is not restricted by other HLA-B â27 subtypes. This finding suggests an important role of HLA subtypes in the restriction of HCV-specific CD8+ responses. With minor HLA subtypes covering up to 39% of specific populations, these findings may have important implications for the selection of epitopes for global vaccines. © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
AB - Background & Aims HLA-Bâ27 is associated with spontaneous HCV genotype 1 clearance. HLA-Bâ27-restricted CD8+ T cells target three NS5B epitopes. Two of these epitopes are dominantly targeted in the majority of HLA-Bâ27+ patients. In chronic infection, viral escape occurs consistently in these two epitopes. The third epitope (NS5B2820) was dominantly targeted in an acutely infected patient. This was in contrast, however, to the lack of recognition and viral escape in the large majority of HLA-Bâ27+ patients. Here, we set out to determine the host factors contributing to selective targeting of this epitope. Methods Four-digit HLA class I typing and viral sequence analyses were performed in 78 HLA-Bâ27+ patients with chronic HCV genotype 1 infection. CD8+ T cell analyses were performed in a subset of patients. In addition, HLA/peptide affinity was compared for HLA-B â27:02 and 05. Results The NS5B2820 epitope is only restricted by the HLA-Bâ27 subtype HLA-Bâ27:02 (that is frequent in Mediterranean populations), but not by the prototype HLA-Bâ27 subtype Bâ27:05. Indeed, the epitope is very dominant in HLA-Bâ27:02+ patients and is associated with viral escape mutations at the anchor position for HLA-binding in 12 out of 13 HLA-Bâ27:02+ chronically infected patients. Conclusions The NS5B2820 epitope is immunodominant in the context of HLA-B â27:02, but is not restricted by other HLA-B â27 subtypes. This finding suggests an important role of HLA subtypes in the restriction of HCV-specific CD8+ responses. With minor HLA subtypes covering up to 39% of specific populations, these findings may have important implications for the selection of epitopes for global vaccines. © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
U2 - 10.1016/j.jhep.2013.08.009
DO - 10.1016/j.jhep.2013.08.009
M3 - Article
SN - 0168-8278
VL - 60
SP - 22
EP - 29
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 1
ER -